Hyaluronidase (Human Recombinant) + Pertuzumab + Trastuzumab
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Hyaluronidase (Human Recombinant)
hyaluronidase-human-recombinant - Pertuzumab
pertuzumab - Trastuzumab
trastuzumab
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| PhesgoCAESEUMXUS | 1,200 mg / 600 mg / 30,000 unit / 20,000 unit / 40 mg / 80 mg | Roche Registration Gmbh |
| pertuzumab, trastuzumab, and hyaluronidase-zzxfUS | 1,200 mg / 600 mg / 30,000 unit / 20,000 unit | Genentech, Inc. |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.